All Clinical Trials
View all active clinical trials around the US.
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Thr...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCE
Blinded Reference Set for Multicancer Early Detection Blood Tests
EARLY DETECTION BLOOD TESTS
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Thr...
TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCE
Blinded Reference Set for Multicancer Early Detection Blood Tests
EARLY DETECTION BLOOD TESTS
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Smoldering Myeloma
No active clinical trials
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials